Tokyo, Japan

Tokyo University of Science , formerly "Science University of Tokyo", informally Rikadai or simply Ridai is a Japanese private university in Shinjuku, Tokyo, Japan. Wikipedia.


Time filter

Source Type

Patent
University of Toyama, Kracie Pharma Ltd., National Cancer Center and Tokyo University of Science | Date: 2015-04-10

The purpose of the present invention is to provide an anticancer agent for potentiating an antitumor effect, alleviating side effects, and further extending the survival rate by concomitant use with a component having an anticancer effect. An anticancer agent combining arctigenin and a component other than arctigenin that has an anticancer effect, in which the anticancer agent may be a combination drug or may be a kit configured from a formulation containing arctigenin and a formulation containing a component that has an anticancer effect, and the concomitant use of arctigenin and the component having an anticancer effect more strongly inhibits tumor growth and reduces the proportion of cancer stem cells in the tumor, making it possible to extend the total survival time and to alleviate side effects caused by the component having an anticancer effect.


Patent
Wako Pure Chemical Industries Ltd. and Tokyo University of Science | Date: 2015-04-21

It is an object of the present invention to provide an electrode having superior charge-discharge capacity, even in the case of using an active material containing silicon. The present invention relates to a binder for a lithium cell comprises a polymer having a monomer unit derived from acrylic acid, and 1 to 2 kinds of monomer units derived from the compound shown by the general formula (I), the general formula (II), or the general formula (III), as constituents, and cross-linked by a cross-linking agent selected from the compounds described by the following general formulae [1] to [13], and the polymer described by the following general formula [14], a composition for producing an electrode of a lithium cell comprising 1) an active material containing silicon, 2) a conductive assistant, and 3) the above-described binder for a cell, and an electrode for a lithium cell having 1) an active material containing silicon, 2) a conductive assistant, 3) the above-described binder for a cell, and (4) a current collector.


A three-dimensional printing system (1) includes: a head (2) to which a first continuous material (FL) including a resin and a second continuous material (FB) including fibers are fed; a platform (3) on which a printing material based on the first and second continuous materials from the head is stacked; a cutting device (10) which is capable of cutting at least fibers; and a controller (5) which controls an operation device including at least one of the head, the platform, and the cutting device.


Patent
Wako Pure Chemical Industries Ltd. and Tokyo University of Science | Date: 2017-03-01

It is an object of the present invention to provide an electrode having superior charge-discharge capacity, even in the case of using an active material containing silicon. The present invention relates to a binder for a lithium cell comprises a polymer having a monomer unit derived from acrylic acid, and 1 to 2 kinds of monomer units derived from the compound shown by the general formula (I), the general formula (II), or the general formula (III), as constituents, and cross-linked by a cross-linking agent selected from the compounds described by the following general formulae [1] to [13], and the polymer described by the following general formula [14], a composition for producing an electrode of a lithium cell comprising 1) an active material containing silicon, 2) a conductive assistant, and 3) the above-described binder for a cell, and an electrode for a lithium cell having 1) an active material containing silicon, 2) a conductive assistant, 3) the above-described binder for a cell, and (4) a current collector.


Patent
Tokyo University of Science and Kaneka Corporation | Date: 2017-05-10

It is an object of the present invention to provide a method for easily producing an antigen-specific B cell population comprising IgG-positive B cells specific to a specific antigen. The present invention provides a method for producing a B cell population, comprising culturing B cells, in which the expression of a Bach2 gene has been increased, in the presence of a means for acting on CD40 and/or a BAFF receptor.


Patent
Tokyo University of Science and Kaneka Corporation | Date: 2015-06-30

It is an object of the present invention to provide a method for easily producing an antigen-specific B cell population comprising IgG-positive B cells specific to a specific antigen. The present invention provides a method for producing a B cell population, comprising culturing B cells, in which the expression of a Bach2 gene has been increased, in the presence of a means for acting on CD40 and/or a BAFF receptor.


Kneller R.,Tokyo University of Science
Nature Reviews Drug Discovery | Year: 2010

Understanding the factors that promote drug innovation is important both for improvements in health care and for the future of organizations engaged in drug discovery research and development. By identifying the inventors of 252 new drugs approved by the US Food and Drug Administration from 1998 to 2007 and their places of work, and also classifying these drugs according to innovativeness, this study investigates the contribution of different types of organizations and regions to drug innovation during this period. The data indicate that drugs initially discovered in biotechnology companies or universities accounted for approximately half of the scientifically innovative drugs approved, as well as half of those that responded to unmet medical needs, although their contribution to the total number of new drugs was proportionately lower. The biotechnology companies were located mainly in the United States. This article presents a comprehensive analysis of these data and discusses potential contributing factors to the trends observed, with the aim of aiding efforts to promote drug innovation. © 2010 Macmillan Publishers Limited. All rights reserved.


Nagashima Y.,Tokyo University of Science
Physics Reports | Year: 2014

This paper is a review of new developments in the experimental field of the efficient emission of the positronium negative ion, a bound state of one positron and two electrons, from alkali-metal coated surfaces. Following the prediction of its existence by Wheeler in 1946, this ion has been one of the most attractive subjects for theorists to investigate in the field of positron physics, resulting in a large number of studies. Though the first observation of the ions, formed using a carbon thin film, was made in 1981 by Mills, there have been few experimental works since, limited by the low-production efficiency achievable for nearly 30years. In 2008, a dramatic effect on the ion emission from tungsten surfaces was discovered upon coating it with Cs. This has opened the door to a new era of experimental investigations of this ion. This paper reports the investigations performed so far. Advances discussed include efficient formation of the ion, its photodetachment and the production of an energy-tunable positronium beam based on the technique of the photodetachment. © 2014 Elsevier B.V.

Loading Tokyo University of Science collaborators
Loading Tokyo University of Science collaborators